Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 2/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | FPR2 | P25090 | 1/20 | 0.52 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.46 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.46 |
| ▸ | DHODH | Q02127 | 1/20 | 0.46 |
| ▸ | ACLY | P53396 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | PNLIP | P16233 | 1/20 | 0.44 |
| ▸ | MET | P08581 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31028179 | 0.86 | MIF (0.51) | SLC6A4HTR2AKDM4EDHODHACLY | |
| SCHEMBL22319398 | 0.86 | MIF (0.51) | SLC6A4HTR2AKDM4EDHODHACLY | |
| SCHEMBL30974578 | 0.86 | KDM4E (0.46) | SLC6A4SLC6A3HTR2ANR4A2KDM4E | |
| SCHEMBL29250437 | 0.86 | KDM4E (0.46) | SLC6A4SLC6A3HTR2ANR4A2KDM4E | |
| SCHEMBL29250430 | 0.85 | SCN8A (0.54) | SLC6A4SLC6A3HTR2APLA2G2AKDM4E | |
| SCHEMBL11421571 | 0.84 | SLC6A3 (0.55) | SLC6A4SLC6A3MEN1KMT2A | |
| SCHEMBL27850308 | 0.83 | SLC6A3 (0.64) | SLC6A4SLC6A3KDM4EALDH1A1CYP1A2 | |
| SCHEMBL21359481 | 0.83 | SLC6A3 (0.52) | SLC6A4SLC6A3PLA2G2ANR4A2KDM4E | |
| SCHEMBL22319382 | 0.82 | PTGER4 (0.66) | ALDH1A1HPGDMEN1KMT2APTGER4 | |
| SCHEMBL22861238 | 0.82 | ROCK2 (0.52) | SLC6A4SLC6A3FPR2SCN9APLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3921310-B1 | NEW N-BENZYL-2-PHENOXYBENZAMIDE DERIVATIVES AS PROSTAGLANDIN E2 (PGE2) RECEPTORS MODULATORS | MEDIBIOFARMA S L (ES) | 2026-01-14 | — | — | EP | disclosed |
| CN-113646299-B | Novel N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2 (PGE 2) receptor modulators | 梅迪比奥法尔玛公司 | 2024-07-26 | — | — | CN | disclosed |
| US-11872226-B2 | N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2 (PGE2) receptors modulators | MEDIBIOFARMA, S.L. (ES) | 2024-01-16 | — | — | US | disclosed |
| US-20220117962-A1 | NEW N-BENZYL-2-PHENOXYBENZAMIDE DERIVATIVES AS PROSTAGLANDIN E2 (PGE2) RECEPTORS MODULATORS | MEDIBIOFARMA, S.L. (ES) | 2022-04-21 | — | — | US | disclosed |
| CN-113646299-A | Novel N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2(PGE2) receptor modulators | 梅迪比奥法尔玛公司 | 2021-11-12 | — | — | CN | disclosed |
| EP-3693359-A1 | NEW N-BENZYL-2-PHENOXYBENZAMIDE DERIVATIVES AS PROSTAGLANDIN E2 (PGE2) RECEPTORS MODULATORS | MEDIBIOFARMA, S.L. (ES) | 2020-08-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220117962-A1 | NEW N-BENZYL-2-PHENOXYBENZAMIDE DERIVATIVES AS PROSTAGLANDIN E2 (PGE2) RECEPTORS MODULATORS | PTGER2, PTGER4, PTGER1 | SLC6A4 1933/4885SLC6A3 3381/4885FPR2 83/4885 |
| US-11872226-B2 | N-benzyl-2-phenoxybenzamide derivatives as prostaglandin E2 (PGE2) receptors modulators | PTGER2, PTGER4, PTGER1 | SLC6A4 2091/4885SLC6A3 3334/4885FPR2 73/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.